Patents by Inventor Sang-Ok Moon

Sang-Ok Moon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aptasensor for detecting female-specific trace of blood and detection apparatus using the same
    Patent number: 10627416
    Abstract: The present invention relates to an aptasensor for detecting a female-specific trace of blood including an aptamer which is used as a biosensor and emits light as the aptamer is bound to the female-specific trace of blood, and a detection apparatus using the same. The aptasensor for detecting a trace of blood to discriminate genders from the trace of blood at a crime scene has a configuration in which the aptasensor emits light as the aptasensor is binding to the female-specific trace of blood, so that genders of a suspect and a victim is distinguished from each other at the crime scene.
    Type: Grant
    Filed: October 2, 2017
    Date of Patent: April 21, 2020
    Assignee: REPUBLIC OF KOREA(NATIONAL FORENSIC SERVICE DIRECTOR MINISTRY OF THE INTERIOR AND SAFETY)
    Inventors: Joo Young Kim, Pil Won Kang, Sang Ok Moon, Man Il Kim, Hye Hyeon Lee, Hye Lim Kim, Ki Won Park, Yang Han Lee, Byung Won Chun
  • APTASENSOR FOR DETECTING FEMALE-SPECIFIC TRACE OF BLOOD AND DETECTION APPARATUS USING THE SAME
    Publication number: 20180143209
    Abstract: The present invention relates to an aptasensor for detecting a female-specific trace of blood including an aptamer which is used as a biosensor and emits light as the aptamer is bound to the female-specific trace of blood, and a detection apparatus using the same. The aptasensor for detecting a trace of blood to discriminate genders from the trace of blood at a crime scene has a configuration in which the aptasensor emits light as the aptasensor is binding to the female-specific trace of blood, so that genders of a suspect and a victim is distinguished from each other at the crime scene.
    Type: Application
    Filed: October 2, 2017
    Publication date: May 24, 2018
    Inventors: Joo Young Kim, Pil Won Kang, Sang Ok Moon, Man Il Kim, Hye Hyeon Lee, Hye Lim Kim, Ki Won Park, Yang Han Lee, Byung Won Chun
  • Reverse Osmosis Water Purifier Having Simple Filter Configuration
    Publication number: 20100116731
    Abstract: Disclosed therein is a reverse osmosis water purifier having a simple filter configuration, which includes filter parts consisted of a sediment-filter, a chlorine-resistant polyamide composite membrane and a post-carbon-filter. The reverse osmosis water purifier can be designed in slim size by omitting a pre-carbon-filter, and provide drinking water of good quality since a portion of the residual chlorine in the feed water pass through the chlorine-resistant polyamide composite membrane to the downstream of said membrane and the residual chlorine can inhibit an adventitious growth of microorganism in the post-carbon-filter or the purified-water tank.
    Type: Application
    Filed: November 6, 2009
    Publication date: May 13, 2010
    Applicant: Woongjin Chemical Co., Ltd.
    Inventors: Jeong-Yul Kim, Sang-Ok Moon, Sung-Pyo Hong, Yong-Doo Jung
  • PHARMACEUTICAL COMPOSITION COMPRISING A-LIPOIC ACID FOR INFLAMMATORY DISEASES
    Publication number: 20080146650
    Abstract: The present invention relates to a pharmaceutical composition containing ?-lipoic acid (LA) as an active ingredient. ?-lipoic acid is an inhibitor of fractalkine expression, and exhibits effects of alleviating inflammation due to endotoxemia by decreasing expression of fractalkine and attachment of endothelial cells to monocytes in endothelial cells of an LPS-induced endotoxemia model.
    Type: Application
    Filed: February 20, 2008
    Publication date: June 19, 2008
    Inventors: Sung-Kwang Park, Won Kim, Six Lee, Sang-Ok Moon
  • Pharmaceutical composition comprising alpha-lipoic acid for inflammatory diseases
    Publication number: 20070072937
    Abstract: The present invention relates to a pharmaceutical composition containing ?-lipoic acid (LA) as an active ingredient. ?-lipoic acid is an inhibitor of fractalkine expression, and exhibits effects of alleviating inflammation due to endotoxemia by decreasing expression of fractalkine and attachment of endothelial cells to monocytes in endothelial cells of an LPS-induced endotoxemia model.
    Type: Application
    Filed: October 26, 2005
    Publication date: March 29, 2007
    Applicant: INDUSTRIAL COOPERATION FOUNDATION CHONBUK NATIONAL UNIVERSITY
    Inventors: Sung-Kwang Park, Won Kim, Sik Lee, Sang-Ok Moon